Apoptotic activity of Newcastle disease virus in comparison with nisin A in MDA-MB-231 cell line
Authors:
- 1 January 2023
- journal article
- research article
- Vol. 14 (1) , 29-37
Abstract
Given the development of drug-resistant cancer cells, designing alternative approaches for cancer treatment seems essential. In this study, we evaluated the anti-tumor effects of nisin A and Newcastle disease virus (NDV) on triple-negative MDA-MB-231 cell line. The MDA-MB-231 cell line was separately and in combination subjected to the different concentrations of a Vero -adapted NDV (JF820294.1) and nisin A. The oncolytic effects of these treatments were analyzed by different cytotoxic and apoptosis techniques including trypan blue staining, MTT assay, acridine orange (EB/AO) staining, colony assay and flow cytometry over time. Nisin A at doses of more than 20.00 mu g mL-1 could represent the anti-viral effects and interfere with the oncolytic activity of NDV. Moreover, the analyses indicated that the anti-proliferative and cytotoxic features of combination therapy were stronger than those of individual NDV groups. However, the most apoptotic effect was seen in NDV experimental groups. Taken together, the results from cytotoxicity tests, flow cytometry and colony assay showed that either of the oncolytic agents had significant effects at low concentrations 72 hr post-treatment. Thereby, they had the potential to be used as new approaches in cancer treatment. (c) 2023 Urmia University. All rights reserved.Keywords
This publication has 41 references indexed in Scilit:
- Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic AdenocarcinomaViruses, 2015
- Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle RecommendationsThe Permanente Journal, 2015
- BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER StressMolecular Therapy, 2015
- Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumorsOncoImmunology, 2015
- Efficacy and transmissibility of Newcastle disease I-2 vaccine strain against a field isolate of virulent ND virus (JF820294.1) in village chickenTropical Animal Health and Production, 2014
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade ImmunotherapyScience Translational Medicine, 2014
- Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune ResponsesMolecular Therapy, 2009
- Radiation Therapy Potentiates Effective Oncolytic Viral Therapy in the Treatment of Lung CancerThe Annals of Thoracic Surgery, 2005
- ApoptosisImmunology Today, 1993
- IMMUNOHISTOCHEMICAL STUDIES ON THE INTERACTION BETWEEN EHRLICH ASCITES TUMOR CELLS AND NEWCASTLE DISEASE VIRUSJournal of Experimental Medicine, 1957